The AltoStar® RT-PCR Kits 1.5 are developed for the simultaneous testing of pathogens by harmonized cycling conditions and enabling the identification of clinical pathogen using the AltoStar® Molecular Diagnostic Workflow. The AltoStar® HCV RT-PCR Kit 1.5 is designed for reliable viral load monitoring of HCV infected patients.
Product not licensed with Health Canada and not FDA cleared or approved. Kit not available in all countries.
The AltoStar® HCV RT-PCR Kit 1.5 is an in vitro diagnostic test, based on real-time PCR technology, for the detection and quantification of human hepatitis C virus (HCV) specific RNA (genotypes 1 to 6) in human EDTA plasma and serum. The AltoStar® HCV RT-PCR Kit 1.5 is configured for use with the CFX96™ Deep Well Dx System (Bio-Rad) in combination with the AltoStar® Automation System AM16, the AltoStar® Purification Kit 1.5 and the AltoStar® Internal Control 1.5.
The AltoStar® HCV RT-PCR Kit 1.5 is intended to be used for viral load monitoring in HCV infection.
Key features
- Detection and quantification of hepatitis C virus (HCV) specific RNA
- Detection of genotypes 1 to 6 in human EDTA plasma and serum
- Quantification Standards calibrated against the 5th WHO International Standard for HCV NAT
(NIBSC code: 14/150) - CE-IVD marked in vitro diagnostic test
- Analytical sensitivity reported in IU/ml
Limit of detection (LoD)
| LoD human EDTA plasma | 11.1 IU/ml |
| LoD human serum | at least 11.1 IU/ml |
Sample types
The following sample types are validated for use with the AltoStar® HCV RT-PCR Kit 1.5:
- Human EDTA plasma
- Human serum
